Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Study on prolonged action cefotoxime].

G Q Xu1, D M Wang, J Zheng

  • 1Department of Pharmaceutics, School of Pharmacy, Shanghai Medical University.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

[Nomogram incorporating OCT-based plaque morphology and computational physiology features for predicting major adverse cardiovascular events in patients with acute coronary syndrome].

Zhonghua xin xue guan bing za zhi·2026
Same author

[Perioperative management of a patient with hemophilia a and high-titer inhibitors and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[Smad3 signaling pathway promotes silica-induced epithelial-mesenchymal transition].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2025
Same author

[Mechanical thrombectomy:recent advancement of the clinical trials].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[Preliminary study on the effect of the third generation flow diverter device in the treatment of intracranial aneurysms].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same journal

[The protective effects of curcumin loaded mesoporous silica nanoparticles on rat cardiomyocytes].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Identification of water buffalo horn and its adulterants using COI barcode].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Construction of the brain-targeting drug carrier through imprinting of nicotinic acetylcholine receptor α7].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Application of magnetic iron oxide nanoparticles in magnetic resonance / photothermal dual-modal imaging].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[Endocytosis pathway and intracellular distribution of heparosan].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
Same journal

[On-line detection of concentration process of Ganmaoling granules by near infrared spectroscopy combined with automatic control system].

Yao xue xue bao = Acta pharmaceutica Sinica·2018
See all related articles

Researchers developed benzathine cefotaxime (BCTX), a prolonged-action cephalosporin. In vivo studies demonstrated BCTX maintained higher serum drug levels longer than cefotaxime sodium (CTX).

Area of Science:

  • Pharmaceutical Chemistry
  • Drug Delivery Systems
  • Pharmacokinetics

Context:

  • Cefotaxime sodium (CTX) is a widely used cephalosporin antibiotic.
  • There is a need for antibiotic formulations with prolonged action to improve patient compliance and therapeutic efficacy.
  • Developing new drug delivery systems is crucial for optimizing pharmacokinetic profiles.

Purpose:

  • To synthesize and characterize a prolonged-action formulation of cefotaxime.
  • To evaluate the physicochemical properties, stability, and in vivo performance of the new formulation.

Summary:

  • A prolonged-action cephalosporin, benzathine cefotaxime (BCTX), was successfully synthesized from cefotaxime sodium and N,N-dibenzylethylene diamine acetate.
  • Characterization confirmed the formation of BCTX, which exhibited low water solubility and a slow intrinsic dissolution rate.

Related Experiment Videos

  • Degradation studies indicated zero-order kinetics for BCTX suspension in water, suggesting good stability.
  • In vivo intramuscular administration in rabbits showed that BCTX maintained higher serum drug concentrations for a longer duration compared to CTX solution.

    • Impact:

    • This research introduces a novel long-acting formulation of cefotaxime, potentially reducing dosing frequency.
    • The findings contribute to the development of advanced drug delivery systems for antibiotics.
    • The improved pharmacokinetic profile of BCTX may lead to enhanced therapeutic outcomes and better patient management.